Skip to main content

MORGAN STANLEY

Position in GANX — Gain Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in GANX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$255,723
-$15,201 QoQ
Shares Held
125,972
-9.8% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 49 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GANX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. GANX ranks #313 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GANX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $255,723 125,972
2026-03-31 $270,924 139,652
2025-12-31 $475,241 147,591
2025-09-30 $275,544 155,675
2025-06-30 $137,721 76,512
2025-03-31 $190,607 99,795
2024-12-31 $191,185 88,512
2024-09-30 $8,544 4,800
2024-06-30 $4,224 3,300
2024-03-31 $10,556 2,800
2023-12-31 $9,142 2,800
2023-09-30 $4,264 1,300
2023-06-30 $3,584 800
2023-03-31 $3,856 800
2022-12-31 $2,504 800
2022-09-30 $3,429 1,052
2022-06-30 $2,880 800
2022-03-31 $3,284 803
2021-12-31 $4,344 800
2021-09-30 $5,956 800
2021-06-30 $8,000 800
2021-03-31 $11,936 800